Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
1830.HK
Strong BuyFull HouseFLAGPerfect Medical Health Management Limited · Healthcare · Hong Kong · $210M · Avg Vol: $104K/d
Operates in aesthetic medicine, a niche category with high pricing power and resilience, exhibiting strong brand loyalty; however, the regulatory environment in the region requires close monitoring.
COMPANY DESCRIPTION
Perfect Medical Health Management Limited is a leading aesthetic medical service provider in Hong Kong, Macau, and mainland China. The company offers non-invasive medical aesthetic treatments and slimming services through its extensive network of high-end clinics. Its competitive moat lies in its premium brand equity, advanced medical technology, and high customer retention rates.
FINANCIAL SUMMARY (HKD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1.3B | 1.4B | 1.4B | 1.1B | -5.8% | 962.7M |
| EPS (HKD) | 0.25 | 0.25 | 0.25 | 0.17 | -12.7% | 0.14 |
| Shares | 1.2B | 1.3B | 1.3B | 1.3B | +1.3% | 1.3B |
| Debt | 311.1M | 240.4M | 268.7M | 216.6M | -11.4% | 134.6M |
| Equity | 494.3M | 612.3M | 497.5M | 379.9M | -8.4% | — |
| Op CF | 513.9M | 560.6M | 497.1M | 332.9M | -13.5% | 339.6M |
| Inv CF | 10.1M | -221.1M | 162.6M | -171.9M | — | — |
| Fin CF | -566.0M | -335.0M | -521.0M | -478.0M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 1830.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 1830.HK | Perfect Medical Health Management Limited(you) | $210M | 100 | Strong Buy |
| 2189.HK | Kato (Hong Kong) Holdings Limited | $63M | 97 | Strong Buy |
| 3309.HK | C-MER Medical Holdings Limited | $129M | 79 | Buy |
| 2138.HK | EC Healthcare | $61M | 71 | Buy |
| 0648.HK | SoftMedx Healthcare Limited | $83M | 60 | Hold |
| 3886.HK | Town Health International Medical Group Limited | $149M | 47 | Hold |
| 2348.HK | Dawnrays Pharmaceutical (Holdings) Limited | $192M | 99 | Strong Buy |
| 8049.HK | Jilin Province Huinan Changlong Bio-pharmacy Company Limited | $168M | 100 | Strong Buy |
| 3839.HK | CPBIO Holding Company Limited | $270M | 96 | Strong Buy |
| 2633.HK | Jacobson Pharma Corporation Limited | $267M | 90 | Strong Buy |
Peer medians: ROE 6.0% · P/E 10.9x · Gross margin 38.0%